Correlation between the immunohistochemical and mRNA expression of glutathione S-transferase-pi and cisplatin plus etoposide chemotherapy response in patients with untreated primary non-small cell lung cancer

  • Authors:
    • T Arai
    • Y Yasuda
    • T Takaya
    • N Yoshimi
    • H Ito
    • H Fujiwara
  • View Affiliations

  • Published online on: July 1, 1997     https://doi.org/10.3892/ijo.11.1.127
  • Pages: 127-131
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Patients who have inoperable lung cancer usually undergo chemotherapy and have problems such as a resistance against chemotherapeutic agents during the treatment. Glutathione S-transferase (GST) is one of the detoxication-related enzymes. We studied the relationship between immunohisto-chemical staining of GST-pi type and cisplatin + etoposide chemotherapy in patients with untreated primary non-small cell lung cancer (NSCLC). Of patients diagnosed as having primary lung cancer, 60 cases (49 men, 11 women; median age, 75.2 years, 35 squamous cell carcinomas and 25 adenocarcinomas) with stage, which were not surgically treatable, were examined immunohistochemically by using anti-GST-pi antibody. Chemotherapy (cisplatin 100 mg/m(2) i.v. day 1, etoposide 100 mg/m(2) i.v. days 1-3) was administered for all 60 patients and was repeated at 28 days for two cycles. After two courses of treatment, the therapeutic response was evaluated. Of 60 cases, 36 (60%) were GST-pi positive and 24 (40%) negative at pretreatment. In 24 patients with GST-pi negative expression, the chemo-therapeutic response rate was 66.7% (16/24), while the response rate was 25% (9/36) in the 36 GST-pi positive patients. The mRNA levels of GST-pi were similar to the immunohistochemical expressions in some of these cases by using reverse transcription-polymerase chain reaction analysis. The results suggest that GST-pi: expression in cancer tissues is related to response to cisplatin + etoposide chemotherapy in untreated primary NSCLC patients, and may be useful as a predictor of chemotherapy response.

Related Articles

Journal Cover

July 1997
Volume 11 Issue 1

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Arai T, Yasuda Y, Takaya T, Yoshimi N, Ito H and Fujiwara H: Correlation between the immunohistochemical and mRNA expression of glutathione S-transferase-pi and cisplatin plus etoposide chemotherapy response in patients with untreated primary non-small cell lung cancer. Int J Oncol 11: 127-131, 1997
APA
Arai, T., Yasuda, Y., Takaya, T., Yoshimi, N., Ito, H., & Fujiwara, H. (1997). Correlation between the immunohistochemical and mRNA expression of glutathione S-transferase-pi and cisplatin plus etoposide chemotherapy response in patients with untreated primary non-small cell lung cancer. International Journal of Oncology, 11, 127-131. https://doi.org/10.3892/ijo.11.1.127
MLA
Arai, T., Yasuda, Y., Takaya, T., Yoshimi, N., Ito, H., Fujiwara, H."Correlation between the immunohistochemical and mRNA expression of glutathione S-transferase-pi and cisplatin plus etoposide chemotherapy response in patients with untreated primary non-small cell lung cancer". International Journal of Oncology 11.1 (1997): 127-131.
Chicago
Arai, T., Yasuda, Y., Takaya, T., Yoshimi, N., Ito, H., Fujiwara, H."Correlation between the immunohistochemical and mRNA expression of glutathione S-transferase-pi and cisplatin plus etoposide chemotherapy response in patients with untreated primary non-small cell lung cancer". International Journal of Oncology 11, no. 1 (1997): 127-131. https://doi.org/10.3892/ijo.11.1.127